Evidence map›Paper›PMID 40637970›Full record

ReviewStem cell reviews and reports2025

Advances in Photobiomodulation: Effects on Mesenchymal Stem Cells and their Paracrine Factors.

Zhuojun Shi, Sining Chen, Wenkai Cai, Wei Chen, Yong Tang

Abstract readReview
PubMed Publisher
In one paragraph

Review in Stem cell reviews and reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Beyond labeling: differential AcRegenerative biomaterials · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zhuojun ShiDepartment of Emergency, Chengdu Second People's Hospital, Chengdu, 610017, Sichuan, China.
Sining ChenDepartment of Nephrology, The Second People's Hospital of Baoshan City, Baoshan, Yunnan, 678000, China.
Wenkai CaiZhenjiang First Foreign Language School, Zhenjiang, 212003, Jiangsu, China.
Wei ChenInstitute of Materials Research and Engineering (IMRE), Agency for Science, Technology and Research (A*STAR), 2 Fusionopolis Way, Innovis #08-03, Singapore, 138634, Republic of Singapore.ORCID 0000-0003-0103-3149
Yong TangDepartment of Emergency, Chengdu Second People's Hospital, Chengdu, 610017, Sichuan, China. 1913671506@qq.com.

Funding

CHENGDU SECOND PEOPLE'S HOSPITAL FOUNDATION, grant number CSPH-2023
6 · The paper itself

Abstract

Mesenchymal stem cells (MSCs) have emerged as pivotal tools in biomedical engineering, owing to their remarkable capacity for tissue repair and regeneration. Photobiomodulation (PBM), a non-invasive and safe physical stimulation technique, has demonstrated significant potential in enhancing MSCs' cellular activity, osteogenic differentiation, and therapeutic efficacy. Despite these promising findings, several challenges hinder the clinical translation of PBM, including the optimization of irradiation parameters to maximize therapeutic outcomes and the standardization of protocols to ensure reproducibility and reliability. This review explores the current advancements in PBM technology and its application in MSC research, with a focus on understanding its mechanisms and therapeutic potential. By delving into the fine-tuning of PBM parameters, including cell factor secretion dynamics, signal transduction pathways, and cell-cell interaction networks, we aim to illuminate how PBM modulates the paracrine functions of MSCs. Additionally, the integration of PBM with biomaterials and engineering technologies presents exciting opportunities for bone tissue engineering and cell therapy. Future research should focus on uncovering the mechanisms by which PBM influences MSC behavior, optimizing its therapeutic parameters, and evaluating its safety and long-term benefits. Such efforts will pave the way for PBM's seamless integration into clinical applications, including complex bone defect repair, thereby advancing its role in precision medicine.

Indexed as

Low-Level Light TherapyMesenchymal Stem CellsParacrine CommunicationAnimalsCell DifferentiationHumansOsteogenesisTissue EngineeringBone tissue engineeringCell therapyMesenchymal stem cellsParacrine factorsPhotobiomodulation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.